NCT02280720已完成4 期
A Randomized Prospective Multicenter Trial to Compare Vascular Healing and Vasodilation at 2 Months After Deployment of TItanium-nitride-oxide-coated OPTIMAX™ Stent and PROMUS-ELEMENT™ Drug-Eluting Stent in Patients With Acute Coronary Syndromes by Means of Optical Coherence Tomography and Coronary Flow Reserve
The Hospital District of Satakunta5 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2013年1月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 5
- 主要终点
- Percentage of uncovered struts
研究概览
简要总结
The purpose of this study is to compare vascular healing of the stented segment after deployment of titanium-nitride-oxide coated cobalt-chromium Optimax™-stent stent and Promus-Element™ everolimus-eluting stent in patients with acute coronary syndromes requiring percutaneous coronary intervention.
- Comparison of OCT and CFR findings of titanium-nitride-oxide coated cobalt-chromium Optimax™-stent and Promus-Element™ everolimus-eluting stent at two months after the index procedure.
- Comparison of intravascular coronary flow reserve measurement to non-invasive transthoracic echocardiography-derived coronary flow reserve measurement.
- Comparison of epicardial vasodilation to coronary microcirculatory vasodilation
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age >18 and <80 years
- •STEMI or NSTEMI (assumed by investigator to be type 1 myocardial infarction, according to universal definitions of MI; EHJ 2007; 28(20):2525-38); or unstable angina (clinical symptoms of chest pain, ecg suggestive of reversible ischemia)
- •Patient is willing to comply with specified follow-up evaluations
- •Patient or legally authorized representative has been informed of the nature of the study, agrees to its provisions and has been provided written informed consent, approved by the appropriate Medical Ethics committee or Institutional Review Board
- •Single de novo or non-stented restenosis lesion
- •Patients with two-vessel disease may have undergone successful treatment of the non-target vessel with approved devices up to and including the index procedure but must be prior to the index target vessel treatment
- •Target lesion (maximum 20 mm length by visual estimation) to be covered by a single stent of maximum 23mm length
- •Reference vessel diameter must be >2.5mm and <4.0mm by visual estimate.
- •The vessel diameter should be measured after pre-dilation procedure and after intracoronary nitroglycerin if vasospasm is suspected
- •Target lesion >50% and <100% stenosed by visual estimate
排除标准
- •Pre-existing diagnosis of diabetes irrespective of its type
- •Impaired renal function (serum creatinine >177micromol/l) or on dialysis
- •Platelet count < 10 e5 cells/mm3
- •Patient has a history of bleeding diathesis or coagulopathy or patients in whom antiplatelet and and/or anticoagulation therapy is contraindicated
- •Patient has received organ transplant or is on a waiting list for any organ transplant
- •Patient has a known hypersensitivity or contraindication to aspirin, heparin/bivalirudin, clopidogrel/prasugrel, stainless steel alloy, or contrast agent that cannot be adequately pre-medicated
- •Patient presents with cardiogenic shock
- •Any significant medical condition which in the Investigator's opinion may interfere with the patient's optimal participation in the study
- •Currently participating in another intestigational drug or device study
- •Unprotected left main disease
- •Ostial target lesions
- •Chronic total occlusion
- •Calcified target lesions that cannot be adequately pre-dilated
- •Target lesion has excessive tortuosity unsuitable for stent delivery and deployment
- •Target lesion involving bifurcation with a side branch larger than 2.0mm in diameter
- •A >30% stenosis proximal or distal to the target lesion that cannot be covered with the same stent
- •Diffuse distal disease
- •Prior stent in the target vessel
结局指标
主要结局
Percentage of uncovered struts
时间窗: 2 months
次要结局
- Coronary flow reserve(2 months)
研究者
研究点 (5)
Loading locations...
相似试验
已完成
不适用
Vascular Healing of DES at 3 MonthsAcute Coronary SyndromeNCT01391871University of Turku46
Unknown
4 期
Comparison of Strut Coverage With OPTIMAX Versus SYNERGY StentsAcute Coronary SyndromeNCT02464397The Hospital District of Satakunta110
已完成
2 期
Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCTAcute Coronary Syndrome (ACS)Myocardial Infarction (MI)AtherosclerosisCoronary Artery DiseaseNCT01405287OrbusNeich60
Unknown
不适用
In-stent Repair and Vessel Reaction of STEMI Patients With OCTDrug-eluting StentsPercutaneous Coronary InterventionOptical Coherence TomographyST-Elevation Myocardial InfarctionNCT04150016Xijing Hospital44
招募中
不适用
A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries.Peripheral Vascular Disease (PVD)Peripheral Arterial Disease (PAD)NCT05246410Acotec Scientific Co., Ltd196